Skip to main content
/
Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.410
+0.030 (2.17%)
At close: May 1, 2025, 4:00 PM
1.360
-0.050 (-3.55%)
After-hours: May 1, 2025, 7:38 PM EDT

Canopy Growth Revenue

Canopy Growth had revenue of 74.76M CAD in the quarter ending December 31, 2024, a decrease of -4.77%. This brings the company's revenue in the last twelve months to 276.75M, down -5.41% year-over-year. In the fiscal year ending March 31, 2024, Canopy Growth had annual revenue of 297.15M, down -10.83%.

Revenue (ttm)
276.75M CAD
Revenue Growth
-5.41%
P/S Ratio
1.15
Revenue / Employee
268,952 CAD
Employees
1,029
Market Cap
221.71M USD

Revenue Chart

Created with Highcharts 11.4.8Canopy Growth Revenue - Annual398.8M​398.8M546.6M​546.6M475.7M​475.7M333.3M​333.3M297.1M​297.1M20202021202220232024-100M200M300M400M500M
* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024297.15M-36.11M-10.83%
Mar 31, 2023333.25M-142.45M-29.94%
Mar 31, 2022475.70M-70.95M-12.98%
Mar 31, 2021546.65M147.88M37.08%
Mar 31, 2020398.77M172.43M76.18%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.19B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.90B
Revenue Rankings

CGC News

More News